Abstract:Abstract Background PFOS and PFOA, extensively used in industrial products like firefighting foams, food packaging, textiles, and various industrial application over the past decades, have been regulated due to their strong persistence, bioaccumulative, and toxicity. In response, industries are developing more degradable and less bioaccumulative PFAS replacements, including shorter chain PFAS and fluoroether alternatives such as perfluorobutanoic acid (PFBA) and hexafluoropropylene oxide dimer acid (HFPO-DA, GenX). However, the health effect of these replacements remains unclear. Despite increasing interest in diagnosing their presence in serum sample, the large number of compound and physicochemical diversity make it difficult to establish appropriate methods, including sample preparation and LC-MS analytical parameter. In this study, we propose appropriate sample preparation procedure based on chemical properties by comparing several PFAS extraction method. Additionally, we demonstrate the significant impact of MS parameters during analysis. Methods Serum samples fortified with 37 native PFAS standards adjusted to 1 ppb, including regulated substances (e.g., PFOS and PFOA) and replacements were prepared. PFAS extraction from fortified serum samples was conducted using weak anion exchange (WAX) cartridge, enhanced matrix removal cartridge (EMR), and liquid-liquid extraction (LLE), Eluates were evaporated and reconstituted in the 50 % acetonitrile solution fortified with isotope-labeled PFAS standards. Signals of 37 of the PFAS compounds were compared while adjusting the curtain gas, ion source gas1, and ion source gas2 flow and source temperatures, respectively. LC-MS/MS analysis was performed using SCIEX 6500 (Sciex, Framingham, MA, USA) combined with ExionLC (Sciex, Framingham, MA, USA, flow rate: 0.3 mL/min). Results The number of carbons in PFAS compounds affected the extraction efficiency in both the LLE and EMR extraction procedure. It was observed that extraction efficiency decreased as the number of carbons increased in both methods. On the other hand, the extraction efficiency of the WAX extraction procedure was affected by the pKa value of acidic group rather than the number of carbons. Specifically, PFAS compounds with carboxylic acid residue exhibited lower extraction efficiency in WAX method compared to sulfonic acid PFAS compounds, and this efficiency was also lower than that of the LLE and EMR methods. In the comparison of MS parameters, it was found that PFAS compounds with phosphate ester structure (6:2diPAP and 8:2diPAP) exhibited a significant decrease in signal when the curtain gas flow was increased. Conversely, very long fluoroalkyl PFAS compounds (such as PFHxDA=C16, PFODA=C18) showed a higher signal at higher curtain gas flow, although partial in-source fragmentation occurred in this case. The ion-source gas and source cone flow did not significantly affect the PFAS signal. Conclusions As the usage of PFAS replacements increases, so does the need for their monitoring. This study underscores that physicochemical diversity of PFAS compounds can significantly affect PFAS monitoring, depending on the sample preparation and MS parameters. We believe that this study will aid in selecting appropriate pretreatment methods and parameters for analyzing specific types of PFAS.

In Vitro Hepatic Clearance Evaluations of Per- and Polyfluoroalkyl Substances (PFAS) across Multiple Structural Categories

Category-Based Toxicokinetic Evaluations of Data-Poor Per- and Polyfluoroalkyl Substances (PFAS) using Gas Chromatography Coupled with Mass Spectrometry

An in vitro-in silico workflow for predicting renal clearance of PFAS

Recent advances in the analysis of per- and polyfluoroalkyl substances (PFAS)-A review

PFAS Exposure Pathways for Humans and Wildlife: A Synthesis of Current Knowledge and Key Gaps in Understanding

Hazard and Risk Characterization of 56 Structurally Diverse PFAS Using a Targeted Battery of Broad Coverage Assays Using Six Human Cell Types.

Hazard and Risk Characterization and Grouping of 56 Structurally Diverse PFAS Using a Targeted Battery of Broad Coverage Assays in Six Human Cell Types

Plasma Protein Binding Evaluations of Per- and Polyfluoroalkyl Substances for Category-Based Toxicokinetic Assessment

In vitro screening of understudied PFAS with a focus on lipid metabolism disruption

Extracorporeal Removal of Per- and Polyfluoroalkyl Substances by Hemoadsorption: In vitro Kinetic Model

Interspecies comparison of metabolism of two novel prototype PFAS

Assessing explicit models of per- and polyfluoroalkyl substances adsorption on anion exchange resins by rapid small-scale column tests

Investigating mouse hepatic lipidome dysregulation following exposure to emerging per- and polyfluoroalkyl substances (PFAS)

Mechanistic Middle-Out Physiologically Based Toxicokinetic Modeling of Transporter-Dependent Disposition of Perfluorooctanoic Acid in Humans

Per‐ and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research

Exploring Route-Specific Pharmacokinetics of PFAS in Mice by Coupling in Vivo Tests and Physiologically Based Toxicokinetic Models.

A food web bioaccumulation model for the accumulation of per- and polyfluoroalkyl substances (PFAS) in fish: how important is renal elimination?

Prediction of the Interactions of a Large Number of Per- and Poly-Fluoroalkyl Substances with Ten Nuclear Receptors

Combustion of C1 and C2 PFAS: Kinetic modeling and experiments

Screening of Potential PFOS Alternatives To Decrease Liver Bioaccumulation: Experimental and Computational Approaches.

B-265 Evaluation of LC-MS/MS Methodologies for 37 Per- and Poly-fluoroalkyl Substances (PFAS) in Serum